By collaborating with ILIFE, Aceso Therapeutics aims to anticipate the design of ACT-101’s clinical study synopsis and secure this next development stage by leveraging the recognized clinical expertise of ILIFE’s team.
By collaborating with ILIFE, Aceso Therapeutics aims to anticipate the design of ACT-101’s clinical study synopsis and secure this next development stage by leveraging the recognized clinical expertise of ILIFE’s team.